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Case Report
SWI enhances vein detection using
gadolinium in multiple sclerosis
Pietro Maggi1, Lorenzo N Mazzoni2, Marco Moretti3,
Matteo Grammatico1, Stefano Chiti4 and Luca Massacesi1
Abstract
Susceptibility weighted imaging (SWI) combined with the FLAIR sequence provides the ability to depict in vivo the
perivenous location of inflammatory demyelinating lesions – one of the most specific pathologic features of multiple
sclerosis (MS). In addition, in MS white matter (WM) lesions, gadolinium-based contrast media (CM) can increase vein
signal loss on SWI. This report focuses on two cases of WM inflammatory lesions enhancing on SWI images after CM
injection. In these lesions in fact the CM increased the contrast between the parenchyma and the central vein allowing as
well, in one of the two cases, the detection of a vein not visible on the same SWI sequence acquired before CM injection.
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Introduction
Susceptibility weighted imaging (SWI) is a gradient
echo sequence that provides additional information in
the evaluation of various neurological diseases by
enhancing the susceptibility contrast in the brain (1).
In particular, susceptibility based magnetic resonance
imaging (MRI) techniques are an invaluable tool to
depict in vivo brain parenchymal veins (2,3).
SWI is usually accomplished by using T1-weighted
(T1W) rapid acquisition gradient echo three-dimen-
sional (3D) sequences, where both magnitude and
phase images are saved. After phase image processing,
a mask is created using phase data and it is subse-
quently multiplied by the magnitude images to produce
the SWI (4).
In SWI, small veins are usually visible as a conse-
quence of the combined effect of T2* signal loss and
phase accumulation, instead contrast in the brain par-
enchyma mainly depends on T2* weighting.
As white matter (WM) lesions in multiple sclerosis
(MS) typically develop around small parenchymal
veins, MRI susceptibility contrast has been mainly
used to characterize veins within inflammatory demye-
linating WM lesions (5), a finding that may improve the
diagnostic accuracy for MS (2).
It has been recently shown that intravenous injection
of paramagnetic gadolinium-based contrast media
(CM) has the possibility to improve the detection of
small veins inside MS WM lesions, by using T2*-
weighted magnitude and phase images (2).
In this report we present the cases of two WM
lesions enhancing after CM injection from two different
patients, one with a definite and the other one with a
possible MS diagnosis. In both cases SWI was applied
to investigate the effect of CM on intralesional vein
detection when the lesion itself appears visibly contrast
enhancing on the same sequence.
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Case report
Case 1
A 52-year-old woman with a 7-year history of relapsing
focal neurological deficits was admitted to the
Neurological Department in order to establish a diag-
nosis. The patient had never been treated with immuno-
suppressive or immunomodulatory drugs. During the
diagnostic workout, the patient underwent brain MRI
examination on a 1.5T scanner (Magnetom Siemens
Aera, Erlangen, Germany). The acquisition protocol
included precontrast media injection (pre-CM) fluid
attenuated inversion recovery (FLAIR), pre- and post-
contrast media injection (post-CM) SWI, and 3D
T1W MPRAGE. Post-CM SWI and subsequently
the MPRAGE were executed 1 min after contrast
administration. On pre-CM FLAIR images, a focal
hyperintense WM matter lesion was detected in the
left peritrigonal region (Fig. 1). The hyperintense
lesion was also visible on the pre-CM SWI that
showed in addition a small faint hypointense round
shaped area in the center of the lesion attributable to
a vein (Fig. 1b). After CM administration the lesion
appeared hyperintense, visibly contrast enhancing, not
only on the MPRAGE (Fig. 1c) but also on the post-
CM SWI while the hypointense central area, previously
barely visible on the pre-CM SWI, appeared now
enlarged (Fig. 1d).
Case 2
A 34-year-old woman with a diagnosis of relapsing
remitting MS, currently under treatment with
Fig. 1. Left peritrigonal focal WM lesion (arrows) appearing hyperintense on (a) the axial pre-CM FLAIR and (b) the axial pre-CM
SWI. In addition SWI shows a small faint hypointense area in the lesion center (magnified view) that can be ascribed to the presence of
a central vein. (c) The lesion appears visibly contrast-enhancing on the axial post-CM MPRAGE and (d) the axial post-CM SWI. The
hypointense vein (already visible on the precontrast SWI) here appears enlarged and the contrast between the small hyperintense
contrast-enhancing lesion and its hypointense central vein, appears increased (magnified view).
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Fingolimod, underwent a brain MRI examination on a
1.5T scanner (Philips Achieva, Best, The Netherlands).
The acquisition protocol included pre-CM FLAIR,
pre- and post-CM T1W axial SE, and SWI. Post-
CM SWI and subsequently the T1W SE were executed
1 min after CM administration. In this patient, an
occipital periventricular WM lesion was detected
(Fig. 2). Before CM injection, the lesion was hyperin-
tense on both FLAIR and SWI, although the pre-CM
SWI did not reveal any hypointense structure within
the lesion area (Fig. 2a and b). After CM administra-
tion the lesion appeared hyperintense, visibly contrast-
enhancing, on both T1W SE (Fig. 2c) and SWI. In
addition, the post-CM SWI showed a linear shaped
area of signal hypointensity in the center of the
lesion previously not visible on the pre-CM SWI
(Fig. 2d).
Discussion
This study describes inflammatory brain WM lesions in
two patients (one with an established and the other with
a probable MS diagnosis) where SWI have been applied
to better characterize in vivo the pathophysiology of
these lesions. In the first case, the pre-CM SWI identi-
fied a focal WM hyperintense lesion, with a correspond-
ing central area of signal loss that can be ascribed to the
presence of a central vein. This kind of signal pattern
has already been described and it is currently under
discussion whether SWI can be used in clinical practice
to improve the differential diagnosis between MS and
other inflammatory diseases (2,6). However, in this
case, CM administration remarkably improved the con-
trast between the hypointense central vein and the sur-
rounding hyperintense lesional parenchyma. Indeed the
Fig. 2. Occipital periventricular WM lesion (arrows) appearing hyperintense on (a) the sagittal pre-CM FLAIR and (b) the pre-CM
axial SWI (magnified view). (c) The lesion appears visibly contrast-enhancing on the post-CM axial T1W SE and (d) the post-CM axial
SWI. The post-CM SWI shows a linear shaped area of signal hypointensity in the lesion center, a parenchymal vein, which is not visible
on the pre-CM SWI (magnified view).
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central vein appeared on the post-CM SWI as a more
intense and enlarged area of signal loss surrounded by a
slightly enlarged hyperintense area due to the subtle
contrast enhancement of this lesion. Furthermore, as
the perivenous location of WM lesions has been largely
shown to be the most specific histopathological feature
of MS (7), the presence of a central vein within the
majority of brain WM lesions in this patient oriented
us toward an MS diagnosis.
In the second case, the pre-CM SWI could not
clearly identify a central vein within the lesion, which
was visible on the SWI only after CM administration.
In both cases the observed improvement of contrast
intensity between the hypointense vein and the sur-
rounding hyperintense lesional parenchyma was most
probably determined by two distinct effects of para-
magnetic CM: the more intense signal loss of intra
veins water molecules (2), and the higher signal inten-
sity in the contrast enhancing WM tissues, due to the
shortening of T1 (8). The combination of these effects,
the first obtained from phase, the second from magni-
tude data, increases the contrast between the central
vein and the lesional parenchyma, allowing, in the
second case, the detection of a central vein only on
the SWI acquired after CM administration.
While the effect of gadolinium based contrast media
on vein signal loss has been widely investigated (2,6), to
our knowledge there are no reports describing the
importance of tissue T1 shortening in vein detection
after CM administration. This last effect can be
observed only in contrast-enhancing lesion, where
blood brain barrier disruption, due to the ongoing
inflammatory process, allows CM to enter the lesion
parenchyma (8).
In conclusion, gadolinium seems to improve the visi-
bility of veins inside multiple sclerosis WM lesions
when using SWI, and this appears to be remarkably
conspicuous when the lesion itself is visibly contrast
enhancing on the same SWI sequence.
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